In addition to PRA, we have shown that the loss-of-function mutation indeed causes additional clinical features, such as obesity, renal and genital anomalies, anosmia, short stature, and dental anomalies. Here, S100A6 is linked to obesity due to melanocortin 4 receptor deficiency.